NDOC

2024

  • Vaishya R, Misra A, Vaish A, Ursino N, D’Ambrosi R. Hand grip strength as a proposed new vital sign of health: a narrative review of evidences. J Health Popul Nutr. 2024 Jan 9;43(1):7. doi: 10.1186/s41043-024-00500-y. PMID: 38195493; PMCID: PMC10777545.
  • Vaishya R, Gupta BM, Kappi MM, Misra A, Kuchay MS, Vaish A. Research on Non-alcoholic Fatty Liver Disease From Indian Subcontinent: A Bibliometric Analysis of Publications During 2001-2022. J Clin Exp Hepatol. 2024 Jan-Feb;14(1):101271. doi: 10.1016/j.jceh.2023.08.007. Epub 2023 Aug 19. PMID: 38076361; PMCID: PMC10709189.

2023

  • Vaishya R, Gupta BM, Misra A, Mamdapur GMN, Walke R, Vaish A. Top 100 highly cited papers from India on COVID-19 research: A bibliometric analysis of the core literature. Diabetes Metab Syndr. 2023 Nov;17(11):102898. doi: 10.1016/j.dsx.2023.102898. Epub 2023 Nov 7. PMID: 37952296.
  • Dutta D, Nagendra L, Bhat S, Mohindra R, Surana V, Misra A. Optimal use of once weekly icodec insulin in type-2 diabetes: An updated meta-analysis of phase-2 and phase-3 randomized controlled trials. Diabetes Metab Syndr. 2023 Oct 11;17(10):102877. doi: 10.1016/j.dsx.2023.102877. Epub ahead of print. PMID: 37832481.
  • Lara-Castor L, Micha R, Cudhea F, Miller V, Shi P, Zhang J, Sharib JR, Erndt-Marino J, Cash SB, Mozaffarian D; Global Dietary Database. Sugar-sweetened beverage intakes among adults between 1990 and 2018 in 185 countries. Nat Commun. 2023 Oct 3;14(1):5957. doi: 10.1038/s41467-023-41269-8. PMID: 37788998.
  • Vaishya R, Misra A. The journal ‘Diabetes and Metabolic Syndrome: Clinical Research and Reviews̕ achieves a double-digit impact factor, marking its ascent. Diabetes Metab Syndr. 2023 Aug;17(8):102830. doi: 10.1016/j.dsx.2023.102830. Epub 2023 Jul 7. PMID: 37531742.
  • Singh AK, Singh A, Singh R, Joshi SR, Misra A. Non-sugar sweeteners and health outcomes in adults without diabetes: deciphering the WHO recommendations in the Indian context. Diabetes Metab Syndr. 2023 Jul 8;17(8):102829. doi: 10.1016/j.dsx.2023.102829. Epub ahead of print. PMID: 37451112.
  • Kumari A, Ranjan P, Vikram NK, Kaur D, Balsarkar G, Malhotra A, Puri M, Batra A, Madan J, Tyagi S, Guleria K, Dabral A, Sarkar S, Nigam A, Anwar W, Kamath S, Bhatla N, Kumari SS, Kumar R, Choranur A, Venkataraman S, Kaur T, Rathore AM, Kaloiya GS, Prakash A, Tiwaskar M, Verma A, Singh R, Sharma KA, Baitha U, Tewary K, Misra A , Guleria R. Evidence and consensus-based clinical practice guideline for the management of obesity and overweight in postpartum women: An AIIMS-DST initiative. J Family Med Prim Care. 2023 May;12(5):812-855. doi: 10.4103/jfmpc.jfmpc_45_22. Epub 2023 May 31. PMID: 37448937; PMCID: PMC10336934.
  • Vaishya R, Misra A, Vaish A, Singh SK. Diabetes and tuberculosis syndemic in India: A narrative review of facts, gaps in care and challenges. J Diabetes. 2023 Jun 8. doi: 10.1111/1753-0407.13427. Epub ahead of print. PMID: 37292055.
  • Zhou XD, Targher G, Byrne CD, Somers V, Kim SU, Chahal CAA, Wong VW, Cai J, Shapiro MD, Eslam M, Steg PG, Sung KC, Misra A, Li JJ, Brotons C, Huang Y, Papatheodoridis GV, Sun A, Yilmaz Y, Chan WK, Huang H, Méndez-Sánchez N, Alqahtani SA, Cortez-Pinto H, Lip GYH, de Knegt RJ, Ocama P, Romero-Gomez M, Fudim M, Sebastiani G, Son JW, Ryan JD, Ikonomidis I, Treeprasertsuk S, Pastori D, Lupsor-Platon M, Tilg H, Ghazinyan H, Boursier J, Hamaguchi M, Nguyen MH, Fan JG, Goh GB, Al Mahtab M, Hamid S, Perera N, George J, Zheng MH. An international multidisciplinary consensus statement on MAFLD and the risk of CVD. Hepatol Int. 2023 May 19:1–19. doi: 10.1007/s12072-023-10543-8. Epub ahead of print. PMID: 37204656; PMCID: PMC10198034.
  • Vaishya R, Misra A, Vaish A. ChatGPT: Is this version good for healthcare and research? Diabetes Metab Syndr. 2023 Apr;17(4):102744. doi: 10.1016/j.dsx.2023.102744. Epub 2023 Mar 15. PMID: 36989584.
  • Meenakshi S, Misra A. Effect of dates on blood glucose and other metabolic variables: A narrative review. Diabetes Metab Syndr. 2023 Feb;17(2):102705.
    doi: 10.1016/j.dsx.2023.102705. Epub 2023 Jan 9. PMID: 36702045.
  • Sachdev M, Misra A. Heterogeneity of Dietary practices in India: current status and implications for the prevention and control of type 2 diabetes. Eur J
    Clin Nutr. 2023 Feb;77(2):145-155. doi: 10.1038/s41430-021-01067-1. Epub 2022 Jan 17. PMID: 35039630.
  • Gulati S, Misra A, Tiwari R, Sharma M, Pandey RM, Upadhyay AD, Chandra Sati H. Premeal almond load decreases postprandial glycaemia, adiposity and
    reversed prediabetes to normoglycemia: A randomized controlled trial. Clin Nutr ESPEN. 2023 Apr;54:12-22. doi: 10.1016/j.clnesp.2022.12.028. Epub
    2022 Dec 29. PMID: 36963852.
  • Gulati S, Misra A, Tiwari R, Sharma M, Pandey RM, Upadhyay AD, Sati HC. Beneficial effects of premeal almond load on glucose profile on oral glucose
    tolerance and continuous glucose monitoring: randomized crossover trials in Asian Indians with prediabetes. Eur J Clin Nutr. 2023 May;77(5):586-595. doi: 10.1038/s41430-023-01263-1. Epub 2023 Feb 2. PMID: 36732571; PMCID: PMC10169634.
  • Nishi SK, Viguiliouk E, Kendall CWC, Jenkins DJA, Hu FB, Sievenpiper JL, Atzeni A, Misra A, Salas-Salvadó J. Nuts in the Prevention and Management of Type 2 Diabetes. Nutrients. 2023 Feb 9;15(4):878. doi: 10.3390/nu15040878. PMID: 36839236; PMCID: PMC9965730.
  • Ranjan P, Vikram NK, Kumari A, Chopra S, Choranur A, Pradeep Y, Puri M, Malhotra A, Ahuja M, Meeta, Batra A, Balsarkar G, Goswami D, Guleria K, Sarkar S, Kachhawa G, Verma A, Kumari MK, Madan J, Dabral A, Kamath S, Rathore AM, Kumar R, Venkataraman S, Kaloiya G, Bhatla N, Kumari SS, Baitha U, Prakash A, Tiwaskar M, Tewary K, Misra A, Guleria R. Evidence and consensus-based clinical practice guidelines for management of overweight and obesity in midlife women: An AIIMS-DST initiative. J Family Med Prim Care. 2022 Dec;11(12):7549-7601. doi: 10.4103/jfmpc.jfmpc_51_22. Epub 2023 Jan 17. PMID: 36994026; PMCID: PMC10041015.
  • Nassar M, Abosheaishaa H, Singh AK, Misra A. Noninsulin-based antihyperglycemic medications in patients with diabetes and COVID-19: A systematic review and meta-analysis. Diabetes. 2023 Jan 23. doi: 10.1111/1753-0407.13359.
  • Dutta D, Mohindra R, Misra A Comment on: “Efficacy and Safety of Saroglitazar in Patients with Cardiometabolic Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials”.
  • Meenakshi S, Misra A . Effect of dates on blood glucose and other metabolic variables: A narrative review. Diabetes Metab Syndr. 2023 Jan 9;17(2):102705. doi:10.1016/j.dsx.2023.102705. PMID: 36702045
  • Singh AK, Singh A, Singh R, Misra A. Efficacy and safety of imeglimin in type 2 diabetes: A systematic review and meta-analysis of randomized placebo-controlled trials. Diabetes Metab Syndr. 2023 Jan 20;17(2):102710. doi: 10.1016/j.dsx.2023.102710. PMID: 36702046
2022

2021

  • Misra A. Majorly Resurgent and Uncontrolled Diabetes During COVID19 Era in India Can Be Contained. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. S1871-4021(21)00153-3.
  • Ranasinghe P, el al. Prevalence and trends of the diabetes epidemic in Urban and Rural India: a pooled systematic review and meta-analysis of 1.7 million adults. Ann Epidemiol.2021 Jun;58:128-148.
  • Sosale A, el al. Steroid use during COVID-19 infection and Hyperglycemia – What a Physician should know. Diabetes & Metabolic Syndrome: Clinical Research & Reviews S1871-4021(21)00185-5.
  • Singh AK, el al. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India Diabetes and Metabolic Syndrome Clinical Research and Reviews. May 2021.
  • Pal R, el al. Resurgence of COVID-19 and diabetes in India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (2021) 1037e1038.
  • Ghosh A, et al. Glycemic parameters in patients with new-onset diabetes during COVID-19 pandemic are more severe than in patients with new-onset diabetes before the pandemic: NOD COVID India Study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (2021) 215e220.
  • Kesavadev J, et al. Blood glucose levels should be considered as a new vital sign indicative of prognosis during hospitalization. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (2021) 221e227
  • Misra A, el al. Heterogeneity in presentation of hyperglycaemia during COVID-19 pandemic: A proposed classification. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (2021) 403e406
  • Pal R, et al. COVID-19 vaccination in patients with diabetes mellitus: Current concepts, uncertainties and challenges. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (2021) 505e508
  • Mohan V, at al. Type 2 diabetes in the young in South Asia: Clinical heterogeneity and need for aggressive public health measures. Journal of Diabetes. 2021;1–3.
  • Mishra A, et al. Exacerbation of hyperglycemia in patients with type 2 diabetes after vaccination for COVID19: Report of three cases. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. S1871-4021(21)00162-4
  • Tyagi K, et al. Breakthrough COVID19 infections after vaccinations in healthcare and other workers in a chronic care medical facility in New Delhi, India. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (2021) 1007e1008
  • Gopalan S, et al. Education and screening for obesity, hypertension, and diabetes (including gestational diabetes) “at the doorstep” of women from nine underprivileged urban areas in Delhi National Capital Region. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (2021) 102209
  • Unnikrishnan R and Misra A. Diabetes and COVID19: a bidirectional relationship. Nutr Diabetes. 2021 Jun 23;11(1):21. doi: 10.1038/s41387-021-00163-2.
  • Sarveswaran G et al. Management of diabetes mellitus through tele consultation during COVID-19 and similar scenarios – Guidelines from Indian Council of Medical Research (ICMR) expert group. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (2021) 102242
  • Singh AK et al. Non-insulin anti-diabetic agents in patients with type 2 diabetes and COVID-19: A Critical Appraisal of Literature. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (2021) 159e167
  • Unnikrishnan R and Misra A. Diabetes and COVID19: a bidirectional relationship. Nutrition and Diabetes (2021) 11:21
  • Ghosh A and Misra A. Marked hyperglycemia and ketosis in a non-obese patient with new onset diabetes and very mild COVID-19 symptoms: A case report. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (2021) 213e214
  • Raveendran AV and Misra A. Post COVID-19 Syndrome (“Long COVID”) and Diabetes: Challenges in Diagnosis and Management. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (2021) 102235
  • Jayawardena R, et  Impact of the vitamin D deficiency on COVID-19 infection and mortality in Asian countries. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15 (2021) 757e764
  • Singh AK, el al. Do SGLT-2 inhibitors exhibit similar cardiovascular benefit in patients with heart failure with reduced or preserved ejection fraction? Journal of Diabetes. 2021;1–5.
  • Sharma M, et al. Differential expression of insulin receptor substrate-1(IRS-1) in visceral and subcutaneous adipose depots of morbidly obese subjects undergoing bariatricsurgery in a tertiary care center in north India; SNP analysis and correlation with metabolic profile. Diabetes Metab Syndr May-Jun 2021;15(3):981-986.
  • Mulakavalupil B, et al. Absence of Case of Mucormycosis (March 2020eMay 2021) under strict protocol driven management care in a COVID-19 specific tertiary care intensive care unit.

2020 

  • Luthra A and Misra A. Escalating cost of oral and injectable antihyperglycemic drugs; are newer medications worth their price? A perspective from India and other developing countries. Diabetes Metab Syndr, 2020. 14(2): p. 167-169.
  • Kehar S and Misra A. Mango: A fruit too far in patients with diabetes? (or is it?). Diabetes Metab Syndr, 2020. 14(2): p. 135-136.
  • Bhatt SP, et al. Vitamin D Supplementation in Overweight/obese Asian Indian Women with Prediabetes Reduces Glycemic Measures and Truncal Subcutaneous Fat: A 78 Weeks Randomized Placebo-Controlled Trial (PREVENT-WIN Trial). Sci Rep, 2020. 10(1): p. 220.
  • Gulati S, et al. The influence of polymorphisms of fat mass and obesity (FTO, rs9939609) and vitamin D receptor (VDR, BsmI, TaqI, ApaI, FokI) genes on weight loss by diet and exercise interventions in non-diabetic overweight/obese Asian Indians in North India. Eur J Clin Nutr, 2020.
  • Misra A. Dietary cholesterol advisory from American Heart Association: Implications for India and other developing countries. Diabetes Metab Syndr, 2020. 14(2): p. 107-108.
  • Ghosh A, et al. Telemedicine for diabetes care in India during COVID19 pandemic and national lockdown period: Guidelines for physicians. Diabetes Metab Syndr. 2020 Apr 4;14(4):273-6
  • Bhatt SP, et al. rs7903146 (C/T) polymorphism of Transcription factor 7 like 2 (TCF7L-2) gene is independently associated with non-alcoholic fatty liver disease in Asian Indians. Diabetes Metab Syndr. 2020 Feb 21;14(3):175-80.
  • Gupta R, et al. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr. 2020 Mar 10;14(3):211-2.
  • Gupta R, et al. Marked erythrocytosis during treatment with sodium glucose cotransporter-2 inhibitors-report of two cases. Diabetes Res Clin Pract. 2020 Mar 26;162:108127.
  • Gupta R, Misra A. Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infectionwith reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc). Diabetes Metab Syndr. 2020 Mar 25;14(3):251-4.
  • Jha A, et al. Dipeptidyl peptidase 4 inhibitors linked bullous pemphigoid in patients with type 2 diabetes mellitus: A series of 13 cases. Diabetes Metab Syndr. 2020 Mar 4;14(3):213-6.
  • Misra A. Doctors and healthcare workers at frontline of COVID 19 epidemic: Admiration, a pat on the back, and need for extreme caution. Diabetes Metab Syndr. 2020 Mar 22;14(3):255-6.
  • Misra A. Diabetes-related research in India and other south Asian countries is inadequate requiring more funding, coaching and structure. Diabetes Metab Syndr. 2020 Mar – Apr;14(2):171-2.
  • Singh AK, et al. Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes Metab Syndr. 2020 Apr 9;14(4):303-10.
  • Singh AK, et al. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers. Diabetes Metab Syndr. 2020 Apr 9;14(4):283-7.
  • Singh AK, et al. Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to India and other developing countries. Diabetes Metab Syndr. 2020 Mar 26;14(3):241-6.
  • Ghosal S, et al. Estimation of effects of nationwide lockdown for containing coronavirus infection on worsening of glycosylated haemoglobin and increase in diabetes-related complications: A simulation model using multivariate regression analysis. Diabetes Metab Syndr. 2020 Apr 10;14(4):319-23.
  • Gopalan H and Misra A. Innovations and proactive political commitment are required to combat diabetes in India and other developing countries. Diabetes Metab Syndr, 2020. 14(1): p. 39-41.
  • Misra A. Way forward for the Journal in times of escalating challenges. Diabetes Metab Syndr, 2020. 14(1): p. 43.
  • Gopalan HS, Misra A. COVID-19 pandemic and challenges for socio-economic issues, healthcare and National Health Programs in India. Diabetes Metab Syndr. 2020 May 30;14(5):757-9.
  • Ghosh A, et al. Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India. Diabetes Metab Syndr. 2020 Jun 2;14(5):917-20.
  • Ghosal S, et al. Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: A cohort analysis. Diabetes Metab Syndr. 2020 Jun 19;14(5):949-52.
  • Jayawardena R, Misra A. Editorial: Balanced diet is a major casualty in COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 14 (2020) 1085e1086
  • Diabetes, National Diabetes Obesity Cholesterol, Foundation, Diabetes Expert Group, India. Strict glycemic control is needed in times of COVID19 epidemic in India: A Call for action for all physicians. Diabetes & Metabolic Syndrome: Clinical Research & Reviews14 (2020) 1579e1581.
  • Diabetes, National Diabetes Obesity Cholesterol, Foundation Nutrition Expert Group, India. Balanced nutrition is needed in times of COVID19 epidemic in India: A call for action for all nutritionists and physicians. Diabetes Metab Syndr. 2020;14(6):1747-50.
  • Singh AK, et al. Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies. Diabetes Metab Syndr.Jul-Aug 2020;14(4):641-648.
  • Singh AK, et al. Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician’s perspective.Diabetes Metab SyndrSep-Oct 2020;14(5):971-978.
  • Singh AK, et al. Hydroxychloroquine in patients with COVID-19: A Systematic Review and meta-analysis.Diabetes Metab Syndr Jul-Aug 2020;14(4):589-596.
  • Gupta R, et al. Diabetes and COVID-19: evidence, current status and unanswered research questions.Eur J Clin Nutr. 2020 Jun;74(6):864-870.
  • Singh AK, Misra A. Editorial: Herd mentality, herds of migrants/people, and COVID-19 in India.Diabetes Metab Syndr.Jul-Aug 2020;14(4):497.
  • Jayawardena R, et al. Exploring the Therapeutic Benefits of Pranayama (Yogic Breathing): A Systematic Review.Int J Yoga. 2020 May-Aug;13(2):99-110.
  • Misra A, Bloomgarden Z. Diabetes during the COVID-19 pandemic: A global call to reconnect with patients and emphasize lifestyle changes and optimize glycemic and blood pressure control.J Diabetes. 2020 Jul;12(7):556-557.
  • Anoop S, et al. A Body shape index significantly predicts MRI-defined abdominal adipose tissue depots in non-obese Asian Indians with type 2 diabetes mellitus. BMJ Open Diab Res Care 2020;8:e001324. doi:10.1136/bmjdrc-2020-001324.
  • Shayak K, et al. Temporary Immunity and Multiple Waves of COVID-19.About 1/3rd of north Indian patients less than 50 years of age with type 2 diabetes have high pulse wave velocity indicating high risk of atherosclerosis. 10.1101/2020.07.01.20144394; July ,2020.
  • Doctors and healthcare workers at frontline of COVID 19 epidemic: Admiration, a pat on the back, and need for extreme caution Pubmed, Diabetes and Metabolic Syndrome Clinical Research & Reviews, Volume 14, Issue 4, July–August 2020, Pages 283-287
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102612/
  • Contentious issues and evolving concepts in the clinical presentation and management of patients with COVID-19 infection with reference to use of therapeutic and other drugs used in Co-morbid diseases (Hypertension, diabetes etc), Diabetes and Metabolic Syndrome Clinical Research & Reviews, Volume 14, Issue 4, July–August 2020, Pages 283-287
    https://pubmed.ncbi.nlm.nih.gov/32247213
  • Clinical Considerations for Patients With Diabetes in Times of COVID-19 Epidemic Publication Pubmed
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7102582/
  • Metabolic Memory: Evolving Concepts Publication: Pubmed
    https://pubmed.ncbi.nlm.nih.gov/29091343/